SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biochem Pharma (BCHE) -- Ignore unavailable to you. Want to Upgrade?


To: Steve Childs who wrote (203)1/6/1998 7:47:00 AM
From: biodoc  Read Replies (1) | Respond to of 783
 
nelfinavir and 3-TC are NOTcompetitor drugs. Single agent therapy is no longer appropriate. Current regimens include at least one protease inhibitor (such as AGPH's drug) and two other drugs such as 3-TC (BCHE's) drug, AZT, DDI, DDC etc.